Royce & Associates LP Reduces Stock Holdings in Astrana Health, Inc. $ASTH

Royce & Associates LP cut its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 15.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 259,353 shares of the company’s stock after selling 48,135 shares during the period. Royce & Associates LP owned approximately 0.46% of Astrana Health worth $7,353,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Quantbot Technologies LP grew its stake in shares of Astrana Health by 384.4% in the 3rd quarter. Quantbot Technologies LP now owns 40,659 shares of the company’s stock valued at $1,153,000 after buying an additional 32,265 shares during the period. Bastion Asset Management Inc. acquired a new position in Astrana Health in the third quarter valued at approximately $604,000. Public Sector Pension Investment Board grew its position in Astrana Health by 18.3% in the third quarter. Public Sector Pension Investment Board now owns 167,490 shares of the company’s stock worth $4,748,000 after acquiring an additional 25,949 shares during the period. Linden Thomas Advisory Services LLC grew its position in Astrana Health by 4.4% in the third quarter. Linden Thomas Advisory Services LLC now owns 28,665 shares of the company’s stock worth $813,000 after acquiring an additional 1,199 shares during the period. Finally, Diamond Hill Capital Management Inc. increased its stake in Astrana Health by 33.0% during the third quarter. Diamond Hill Capital Management Inc. now owns 361,264 shares of the company’s stock worth $10,242,000 after acquiring an additional 89,733 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 4.4%

NASDAQ ASTH opened at $25.59 on Thursday. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.40 and a current ratio of 1.40. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 55.63, a PEG ratio of 0.68 and a beta of 0.91. The firm has a 50 day simple moving average of $23.57 and a 200-day simple moving average of $26.24. Astrana Health, Inc. has a one year low of $18.08 and a one year high of $34.80.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Monday, March 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.39. The company had revenue of $950.53 million for the quarter, compared to analyst estimates of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The firm’s quarterly revenue was up 42.9% on a year-over-year basis. During the same period in the prior year, the business earned ($0.15) EPS. Equities research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on ASTH shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Needham & Company LLC began coverage on shares of Astrana Health in a report on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective on the stock. TD Cowen lowered their target price on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Jefferies Financial Group reiterated a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. Finally, Zacks Research lowered shares of Astrana Health from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 10th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $35.33.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.